4.5 Article

Multiple sclerosis, a treatable disease

Journal

CLINICAL MEDICINE
Volume 17, Issue 6, Pages 530-536

Publisher

ROY COLL PHYS LONDON EDITORIAL OFFICE
DOI: 10.7861/clinmedicine.17-6-530

Keywords

Diagnostic criteria; epidemiology; multiple sclerosis; progressive multiple sclerosis; treatments

Funding

  1. National Institute for Health Research (NIHR), University College London Hospitals (UCLH)/UCL Biomedical Research Centre (BRC)

Ask authors/readers for more resources

This article reviews our current understanding and modern treatment of multiple sclerosis (MS). MS is a disabling condition resulting in devastating social and economic impacts. As MS can affect any part of the central nervous system, the presentation is often diverse; however, there are key features that can be useful in the clinic. We comment on the diagnostic criteria and review the main subtypes of MS, including clinically isolated syndrome, relapsing remitting MS, secondary progressive MS and primary progressive MS. Although the underlying aetiology of MS is still not known, we summarise those with most evidence of association. Finally, we aim to present treatment strategies for managing the acute relapse, disease-modifying therapies and MS symptoms. This review highlights that progressive MS is an area where there is currently a paucity of available disease modifying treatments and this will be a major focus for future development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available